Mylene Meyer
Overview
Explore the profile of Mylene Meyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meyer M, Spitz E, Colnat-Coulbois S, Benatru I, Guehl D, Hainque E, et al.
J Neurol Sci
. 2024 Jun;
462:123093.
PMID: 38908172
Background: Recent literature suggests that taking into consideration and evaluating preoperative expectations of Parkinson's disease (PD) patients candidates to deep brain stimulation (DBS), can contribute to treatment effectiveness. However, few...
2.
Meyer M, Montel S, Colnat-Coulbois S, Frismand S, Llorca P, Vidailhet P, et al.
J Geriatr Psychiatry Neurol
. 2024 May;
37(6):448-460.
PMID: 38801752
Objective: Less is known concerning the evolution of coping strategies before and after deep brain stimulation (DBS) in Parkinson's disease (PD) patients. Methods: In a randomized controlled trial, coping was...
3.
Morel H, Bailly L, Urbanczyk C, Herve D, Berroir S, Le Bouc R, et al.
Neurol Genet
. 2023 Apr;
9(3):e200069.
PMID: 37063705
Objectives: To refine the clinical spectrum of a very recently identified phenotype associated with end-truncating pathogenic variations. Methods: Detailed clinical, neuropsychological, and MRI investigation of 6 patients from 2 unrelated...
4.
Meyer M, Colnat-Coulbois S, Frismand S, Vidailhet P, Llorca P, Schwan R, et al.
J Neural Transm (Vienna)
. 2023 Apr;
130(5):647-654.
PMID: 37022502
Parkinson's disease (PD) is a neurodegenerative disease, that combines motor and non-motor disorders, and alters patients' autonomy. Even if subthalamic nucleus deep brain stimulation (STN-DBS) induces undisputable motor improvement, a...
5.
Boussac M, Arbus C, Colin O, Laurencin C, Eusebio A, Hainque E, et al.
Parkinsonism Relat Disord
. 2022 Aug;
103:34-41.
PMID: 36030666
Introduction: There is a growing interest in personality evaluation in Parkinson's disease (PD), following observations of specific temperaments in PD patients. Therefore, our objective was to evaluate personality dimensions from...
6.
Hocquel A, Ravel J, Lambert L, Bonnet C, Banneau G, Kol B, et al.
Neurogenetics
. 2022 Jul;
23(4):241-255.
PMID: 35788923
ATL1-related spastic paraplegia SPG3A is a pure form of hereditary spastic paraplegia. Rare complex phenotypes have been described, but few data concerning cognitive evaluation or molecular imaging of these patients...
7.
Devignes Q, Daoudi S, Viard R, Lopes R, Betrouni N, Kuchcinski G, et al.
J Parkinsons Dis
. 2022 May;
12(5):1507-1526.
PMID: 35599498
Background: Parkinson's disease mild cognitive impairment (PD-MCI) is frequent and heterogenous. There is no consensus about its influence on subthalamic deep brain stimulation (STN-DBS) outcomes. Objective: To determine the prevalence...
8.
Blonski M, Obara T, Brzenczek C, Pouget C, Dillier C, Meyer M, et al.
Front Oncol
. 2022 Mar;
12:827897.
PMID: 35311144
Background: Study RTOG 9802 in high-risk diffuse low-grade gliomas (DLGGs) showed the potential synergistic effect on survival of the procarbazine, CCNU, and vincristine (PCV) radiotherapy (RT) combination. Limited data on...
9.
Hingray C, Ertan D, Reuber M, Lother A, Chrusciel J, Tarrada A, et al.
Epilepsia
. 2022 Mar;
63(6):1500-1515.
PMID: 35305025
Objective: Current concepts highlight the neurological and psychological heterogeneity of functional/dissociative seizures (FDS). However, it remains uncertain whether it is possible to distinguish between a limited number of subtypes of...
10.
Boussac M, Arbus C, Klinger H, Eusebio A, Hainque E, Corvol J, et al.
J Parkinsons Dis
. 2021 Dec;
12(2):699-711.
PMID: 34897100
Background: Deep brain stimulation of the sub-thalamic nucleus (DBS-STN) reduces symptoms in Parkinson's disease (PD) patients with motor fluctuations. However, some patients may not feel ameliorated afterwards, despite an objective...